The 31-gene expression profile test informs sentinel lymph node biopsy decisions in patients with cutaneous melanoma: results of a prospective, multicenter study-Reference-Cited by-同舟云学术

The 31-gene expression profile test informs sentinel lymph node biopsy decisions in patients with cutaneous melanoma: results of a prospective, multicenter study

Published:2023-01-16 Issue:3 Volume:39 Page:417-423
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Yamamoto Maki¹,Sickle-Santanello Brenda²,Beard Timothy³,Essner Richard⁴,Martin Brian⁵,Bailey Christine N.⁵,Guenther J. Michael⁶

Affiliation:

1. School of Medicine, University of California-Irvine, Orange, CA, USA

2. Surgical Oncology Associates of Columbus, Columbus, OH, USA

3. Bend Memorial – Total Care, Bend, OR, USA

4. Melanoma and Cutaneous Oncology Research Program, Saint John’s Cancer Institute, Santa Monica, CA, USA

5. Castle Biosciences, Inc, Friendswood, TX, USA

6. General Surgery, St. Elizabeth Physicians, Edgewood, KY, USA

Funder

Castle Biosciences

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2023.2165813

Reference33 articles.

1. Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual

2. National Comprehensive Cancer. NCCN guidelines melanoma: cutaneous. Version 2.2022. 2022.

3. Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma

4. Prognostic role of sentinel lymph node biopsy for patients with cutaneous melanoma: A retrospective study of surveillance, epidemiology, and end-result population-based data

5. Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of the Melanoma Institute of Australia’s Sentinel Lymph Node Biopsy Risk Prediction Tool for Cutaneous Melanoma;Annals of Surgical Oncology;2024-01-12

2. Management of melanoma: can we use gene expression profiling to help guide treatment and surveillance?;Clinical & Experimental Metastasis;2023-12-08

3. The Integrated i31-GEP Test Outperforms the MSKCC Nomogram at Predicting SLN Status in Melanoma Patients;Anticancer Research;2023-09-29

4. RE: A Clinical Decision Tool to Calculate Pretest Probability of Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma;Annals of Surgical Oncology;2023-07-03